Survival Improvements in Ovarian Cancer by using Sorafenib
According to a new study, topotecan and Nexavar (generic Sorafenib) when combined, and there after used as a maintenance therapy has significantly improve the survival outcomes in women who are suffering from platinum-resistant ovarian cancer.
Source: https://shorturl.at/eiCDL
#OvarianCancerSurvival
#SorafenibTreatment
#cancerresearch
#SurvivalImprovements
#ovariancancerawareness
#MedicalAdvancements
#TreatmentInnovation
#fightagainstcancer
#HealthcareBreakthroughs
#cancersurvivor
According to a new study, topotecan and Nexavar (generic Sorafenib) when combined, and there after used as a maintenance therapy has significantly improve the survival outcomes in women who are suffering from platinum-resistant ovarian cancer.
Source: https://shorturl.at/eiCDL
#OvarianCancerSurvival
#SorafenibTreatment
#cancerresearch
#SurvivalImprovements
#ovariancancerawareness
#MedicalAdvancements
#TreatmentInnovation
#fightagainstcancer
#HealthcareBreakthroughs
#cancersurvivor
02:52 AM - Feb 23, 2024
Only people mentioned by 911GlobalMeds in this post can reply